BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 28236605)

  • 21. Curcumin in Depression: Potential Mechanisms of Action and Current Evidence-A Narrative Review.
    Ramaholimihaso T; Bouazzaoui F; Kaladjian A
    Front Psychiatry; 2020; 11():572533. PubMed ID: 33329109
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of Curcumin on Anthropometric Measures: A Systematic Review on Randomized Clinical Trials.
    Hariri M; Haghighatdoost F
    J Am Coll Nutr; 2018; 37(3):215-222. PubMed ID: 29313748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic Effects of Curcumin-From Traditional Past to Present and Future Clinical Applications.
    Bachmeier BE; Melchart D
    Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31374813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An Update on the Exploratory Use of Curcumin in Neuropsychiatric Disorders.
    Lamanna-Rama N; Romero-Miguel D; Desco M; Soto-Montenegro ML
    Antioxidants (Basel); 2022 Feb; 11(2):. PubMed ID: 35204235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of Curcumin in Common Musculoskeletal Disorders: a Review of Current Laboratory, Translational, and Clinical Data.
    Peddada KV; Peddada KV; Shukla SK; Mishra A; Verma V
    Orthop Surg; 2015 Aug; 7(3):222-31. PubMed ID: 26311096
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Curcumin and Resveratrol in the Management of Cognitive Disorders: What is the Clinical Evidence?
    Mazzanti G; Di Giacomo S
    Molecules; 2016 Sep; 21(9):. PubMed ID: 27649135
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of Curcumin on Depression and Anxiety: A Narrative Review of the Recent Clinical Data.
    Khodadadegan MA; Azami S; Guest PC; Jamialahmadi T; Sahebkar A
    Adv Exp Med Biol; 2021; 1291():283-294. PubMed ID: 34331697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploring the Contribution of Curcumin to Cancer Therapy: A Systematic Review of Randomized Controlled Trials.
    de Waure C; Bertola C; Baccarini G; Chiavarini M; Mancuso C
    Pharmaceutics; 2023 Apr; 15(4):. PubMed ID: 37111761
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Curcumin: the potential for efficacy in gastrointestinal diseases.
    Irving GR; Karmokar A; Berry DP; Brown K; Steward WP
    Best Pract Res Clin Gastroenterol; 2011 Aug; 25(4-5):519-34. PubMed ID: 22122768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Effect of Curcumin Differs on Individual Cognitive Domains across Different Patient Populations: A Systematic Review and Meta-Analysis.
    Tsai IC; Hsu CW; Chang CH; Tseng PT; Chang KV
    Pharmaceuticals (Basel); 2021 Nov; 14(12):. PubMed ID: 34959636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antioxidant Potential of Curcumin-A Meta-Analysis of Randomized Clinical Trials.
    Jakubczyk K; Drużga A; Katarzyna J; Skonieczna-Żydecka K
    Antioxidants (Basel); 2020 Nov; 9(11):. PubMed ID: 33172016
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A systematic review of the antidepressant effects of curcumin: Beyond monoamines theory.
    Matias JN; Achete G; Campanari GSDS; Guiguer ÉL; Araújo AC; Buglio DS; Barbalho SM
    Aust N Z J Psychiatry; 2021 May; 55(5):451-462. PubMed ID: 33673739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of HIV-associated diarrhea with curcumin.
    Conteas CN; Panossian AM; Tran TT; Singh HM
    Dig Dis Sci; 2009 Oct; 54(10):2188-91. PubMed ID: 19051018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Turmeric supplements.
    Med Lett Drugs Ther; 2019 Nov; 61(1585):185-186. PubMed ID: 31770359
    [No Abstract]   [Full Text] [Related]  

  • 35. ALSUntangled 44: curcumin.
    Bedlack R;
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 Nov; 19(7-8):623-629. PubMed ID: 29493344
    [No Abstract]   [Full Text] [Related]  

  • 36. Turmeric.
    Grant KL; Schneider CD
    Am J Health Syst Pharm; 2000 Jun; 57(12):1121-2. PubMed ID: 10911509
    [No Abstract]   [Full Text] [Related]  

  • 37. An overview of curcumin in neurological disorders.
    Kulkarni SK; Dhir A
    Indian J Pharm Sci; 2010 Mar; 72(2):149-54. PubMed ID: 20838516
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Curcumin as an ajuvant treatment of depression: mechanisms of action and application prospects].
    Katasonov AB
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(2):125-131. PubMed ID: 32307422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of curcumin consumption on human chronic diseases: A narrative review of the most recent clinical data.
    Mantzorou M; Pavlidou E; Vasios G; Tsagalioti E; Giaginis C
    Phytother Res; 2018 Jun; 32(6):957-975. PubMed ID: 29468820
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Corrigendum to "The efficacy and acceptability of curcumin for the treatment of depression or depressive symptoms: A systematic review and meta-analysis". [Journal of Affective Disorders 282 (2021) 242-251].
    Zhang Q; Huang H; Liu Z; Wang Z
    J Affect Disord; 2021 Jun; 289():179. PubMed ID: 33836896
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.